Halaven
Halaven is an originator product from Eisai Pharma AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 221.60 to CHF 221.60 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Eisai Pharma AG
- ATC code
- L01XX41
- IT group
- 07.16.10 Cytostatica
- Active substances
- Eribulini mesilas
- Preparation type
- Originator product
- On the SL since
- 01/07/2011
- Last price change
- 01/01/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Lös 1 mg/2ml | Durchstf 2 ml | CHF 188.66 | CHF 221.60 | 01/07/2011 | A | 7680594890015 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
- als Monotherapie für die Behandlung von lokal fortgeschrittenem oder metastasierendem HER2 negativem Mammakarzinom nach Versagen einer Chemotherapie im fortgeschrittenen Stadium. Patienten sollten zuvor ein Anthrazyklin und ein Taxan erhalten haben, es sei denn diese Behandlung war ungeeignet.
- zur Monotherapie des inoperablen Liposarkoms bei Progression nach Chemotherapie im fortgeschrittenen oder metastasierenden Stadium bei Erwachsenen. Patienten sollten zwei vorhergehende Chemotherapien erhalten haben, davon sollte eine eine Anthrazyklin-enthaltende Chemotherapie sein, es sei denn diese Behandlung ist ungeeignet.
FAQ
Is Halaven covered by Swiss health insurance?
Yes, but only under conditions. Halaven is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Halaven cost in Switzerland?
The public price is the maximum price set by the FOPH and for Halaven ranges from CHF 221.60 to CHF 221.60 per pack. The ex-factory price ranges from CHF 188.66 to CHF 188.66. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages